24/7 Customer Support

Digital Therapeutics Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2031

Global Digital Therapeutics Market: By Component (Hardware, Software and Services); Application (Preventive Applications and Treatment/Care-related Applications); Sales Channel (Business-to-business (B2B) and Business-to-consumer (B2C)) and Region—Industry Dynamics, Market Size and Opportunity Forecast until 2031

  • Published Date: 29-Mar-2023  |   Format: pdfpowerpointexcel  |  Report ID: AA0322170
    Delivery: 2 to 4 Hours
Digital Therapeutics Market

View Full Infographic


Report AttributeDetails
Market Size Value in 2022US$ 3,744.3 Mn
Expected Revenue in 2031US$ 27,456.0 Mn
Historic Data2018-2021
Base Year2022
Forecast Period2023-2031
UnitValue (USD Mn)
Segments coveredBy Component, By Application, By Sales Channel, By Region
Key Companies                                                                  2MORROW, Inc., Akili Interactive Labs, Inc., Click Therapeutics, Inc., Fitbit, Inc. (Twine Health, Inc.), Happify, Inc., Kaia Health, Livongo Health, Inc., Medtronic Plc., Omada Health, Inc., Pear Therapeutics, Inc., Proteus Digital Health, Inc., Resmed, Inc. (Propeller Health), Voluntis, Inc., Welldoc, Inc., Other Prominent Players
Customization ScopeGet your customized report as per your preference. Ask for customization


Digital Therapeutics (DTx) is a mobile software application that treats a disease or condition. It provides evidence-based technologies that helps in improving patient outcomes.

Digital therapeutics software application can be used independently or in combination with medications or devices to impact complex healthcare challenges in order to provide patient care and health outcomes.

Digital therapeutics support patients in self-managing symptoms by using digital implements like mobile devices, apps, sensors, virtual reality, the Internet of Things and other tools in order to spur behavioural changes in patients.

The growth rate of the global digital therapeutics market is 23.1%, with an estimated value of US$ 27,456.0 Million by 2031. 

Factors such as increasing use of wearable devices and investment in digital health are driving the growth in the global digital therapeutics market.

The key trends in the digital therapeutics market are the adoption of different strategies by market players such as product launches, acquisition, mergers and partnerships to strengthen their market position at global level.

The treatment/care related application segment lead the global digital therapeutics market in 2022.

The reluctance among people to use digital therapeutics and privacy concerns are major restraining factors faced by digital therapeutics providers which hampers the growth of the market.

Components, application and sales channel are the different segments of the global digital therapeutics market.

The Business-to-Business (B2B) is further bifurcated into Employer, Healthcare Provider, Payers, Pharmaceutical Companies and Others.

Poland is expected to project the highest CAGR in the Europe Digital Therapeutics Market during the forecast period. 

Livongo Health, Inc., Omada Health, Inc., Proteus Digital Health, Inc., Akili Interactive Labs, Inc., 2Morrow Inc., Click Therapeutics Inc., Happify Health, Kaia Health, Teladoc Health, Inc., Medtronic, Pear Therapeutics, Inc., ResMed and Voluntis among others are some key players in the global digital therapeutics market.